BofA Securities analyst Alec W. Stranahan maintained the price target on CG Oncology (NASDAQ: CGON) at $83.00 while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE